FROM PAGE 12

State Guest House Jamuna, according to the Chief Adviser’s Press Wing.

The delegation included senior Chinese academics, investors, and industry leaders from the biomedical, infrastructure, digital, and legal sectors.

Xin-yuan Fu, a leading Chinese biomedical scientist and director of the West China School of Medicine at Sichuan University, praised Professor Yunus’s vision and said he looked forward to working with Bangladeshi academics to help improve people’s lives.

Andrew Zilong Wong, senior adviser to the board of directors of Walvax Biotechnology, and Yuqing Yao, managing director of Walvax Biotech (Singapore), also expressed interest in working with Bangladesh. Walvax has exported vaccines to at least 22 countries.

The delegation informed the chief adviser that they had engaged with Bangladeshi university students on artificial intelligence and digitalisation and expressed admiration for the talent and potential of the country’s youth.

During the meeting, Yunus recalled his long-standing relationship with China, which began through the microcredit movement.

“I had the opportunity to visit remote villages in China and see how people’s lives were being transformed. Later, the Chinese government launched its own programmes inspired by these principles,” he said.

Highlighting the interim government’s priorities, the chief adviser said healthcare remains the top concern.

“Our highest priority is healthcare -- how to integrate digital technology so that doctors and patients can connect effectively, medical histories can be preserved digitally, and appointments can be accessed easily,” he said.

He also emphasised the need for social business models in the pharmaceutical sector.

“Medicines cost pennies to produce, yet are sold for dollars. We want to encourage the establishment of social business pharmaceutical companies that focus on helping people, not just profits,” he said.